Following a quarter in which sales of its sera products declined sharply, Invitrogen officials said last week that they are reviewing the firm’s entire portfolio with a particular focus on the sera business.
 
Additionally, though the officials declined to say whether a divestment of that business was possible, Chairman and CEO Greg Lucier said the firm is currently reviewing whether “we need to be broadly in the sera business” and hopes to know more in six months.
 

To read the full story....

Register for Free.

...and receive Daily News bulletins.

Already have an account?
Login Now.

Researchers have sequenced the northern white rhinoceros to gauge whether it could be brought back from the edge of extinction, the New York Times reports.

Bavaria expands its forensic genetic analyses to include DNA phenotyping, raising discrimination concerns.

Tufts University researchers found a role for miRNA in transmitting stress between generations, the Economist reports.

In Science this week: gut microbiome influences liver cancer growth, spread; and more.